Comparison of nitric oxide level in Behçet’s disease patients with or without psychiatric comorbidity

References

• Behçet, H. Uber Rezidivierende Aphthose Durch Ein Virus Verursachte Geschwure Am Mund, Am Auge, Und An Den Genitalien. Dermatol. Monatsschr. 1937, 105, 1152–1157.
   Google Scholar
• Onder, M.; Gurer, M. A. Behçet’s Disease: An Enigmatic Vasculitis. Clin. Dermatol. 1999, 17(5), 571–576. DOI: 10.1016/S0738-081X(99)00063-2.
   PubMed Web of Science ®Google Scholar
• Gul, A. Behçet’s Disease: An Update on the Pathogenesis. Clin. Exp. Rheumatol. 2001, 19(5), 6–12.
   PubMed Web of Science ®Google Scholar
• Jorizzo, J. L. Behçet’s Disease. In Dermatology in General Medicine, 5th ed.; Fitzpatrick, T. B., Eisen, A. Z., Wolf, K., Freedberg, I. M., Austen, K. F., Eds.; Mc Graw-Hill: New York, 1993; pp 2290–2294.
   Google Scholar
• Rota, S.; Bozkurt, M.; Alkibay, T.; Kocabeyoğlu, O. Behçet Hastalığında Otoantikorlar. Lepra Mecmuasi. 1990, 21, 80–86.
   Google Scholar
• Hamzaoui, K.; Ayed, K.; Hamza, M.; Tourainne, J. L. Natural Killer Cells in Behçet’s Disease. Clin. Exp. Immunol. 1988, 71, 126–131.
   PubMed Web of Science ®Google Scholar
• Parlakpinar, H.; Orum, M. H.; Sagir, M. Pathophysiology of Myocardial Ischemia Reperfusion Injury: A Review. Med. Sci. 2013, 2(4), 935–954. DOI: 10.5455/medscience.2013.02.8082.
   Google Scholar
• Parlakpinar, H.; Orum, M. H.; Acet, A. Caffeic Acid Phenethyl Ester (CAPE) and Myocardial Ischemia Reperfusion (MI/R) Injury. Inonu Univ. J. Health Sci. 2012, 1, 10–15.
   Google Scholar
• Parlakpinar, H.; Orum, M. H.; Acet, A. Aminoguanidine and Cardiovascular System. Inonu Univ. J. Health Sci. 2012, 2, 9–14.
   Google Scholar
• Parlakpinar, H.; Orum, M. H. The Antioxidant Effect of Melatonin on Myocardial Ischemia Reperfusion Injury in Experimental Studies. Med. Sci. 2014, 3(4), 1766–1780. DOI: 10.5455/medscience.2014.03.8162.
   Google Scholar
• Parlakpinar, H.; Sagir, M.; Orum, M. H. Angiotensin II Type 2 Receptor (AT2) and Agonists in Cardiovascular System. J. Turgut. Ozal. Med. Cent. 2013, 20(2), 185–191. DOI: 10.7247/jtomc.20.2.22.
   Google Scholar
• Parlakpinar, H.; Orum, M. H.; Acet, A. Free Oxygen Radicals in Drug-Induced Nephrotoxicity. Firat Univ. J. Health Sci. 2013, 27(1), 51–56.
   Google Scholar
• Parlakpinar, H.; Orum, M. H.; Ozhan, O. Myocardial Necrosis Markers in Myocardial Ischemia Reperfusion (MI/R) Injury: A Review. Med. Sci. 2017, 6(1), 163–171. DOI: 10.5455/medscience.2016.05.8520.
   Google Scholar
• Wanchu, A.; Khullar, M.; Deodhar, S. D.; Bambery, P. Nitric Oxide Synthesis Is Increased in Patients with Systemic Lupus Erythematosus. Int. Rheumatol. 1998, 18, 41–43. DOI: 10.1006/niox.1999.0261.
   PubMed Web of Science ®Google Scholar
• Evereklioglu, C. Current Concepts in the Etiology and Treatment of Behcet Disease. Surv. Ophthalmol. 2005, 50, 297–350. DOI: 10.1016/j.survophthal.2005.04.009.
   PubMed Web of Science ®Google Scholar
• Baatz, H.; Pleyer, U. Modulation of Leukocyte-Endothelium Interaction by Nitric Oxide Synthase Inhibitors: Effects on Leukocyte Adhesion in Endotoxin Induced Uveitis. Inflamm. Res. 2001, 50, 534–543. DOI: 10.1007/PL00000231.
   PubMed Web of Science ®Google Scholar
• Talarowska, M.; Gałecki, P.; Maes, M.; Orzechowska, A.; Chamielec, M.; Bartosz, G.; Kowalczyk, E. Nitric Oxide Plasma Concentration Associated with Cognitive Impairment in Patients with Recurrent Depressive Disorder. Neurosci. Lett. 2012, 510(2), 127–131. DOI: 10.1016/j.neulet.2012.01.018.
   PubMed Web of Science ®Google Scholar
• Selley, M. L. Increased (e)-4-hydroxy-2-nonenal and Asymmetric Dimethyl Arginine Concentrations and Decreased Nitric Oxide Concentrations in the Plasma of Patients with Major Depression. J. Affect. Disord. 2004, 80(2–3), 249–256. DOI: 10.1016/S0165-0327(03)00135-6.
   PubMed Web of Science ®Google Scholar
• Lee, B. H.; Lee, S. W.; Yoon, D.; Lee, H. J.; Yang, J. C.; Shim, S. H.; Kim, D. H.; Ryu, S. H.; Han, C.; Kim, Y. K. Increased Plasma Nitric Oxide Metabolites in Suicide Attempters. Neuropsychobiology. 2006, 53, 127–132. DOI: 10.1159/000092542.
   PubMed Web of Science ®Google Scholar
• Orum, M. H.; Egilmez, O. B. Psychiatric Presentation of Hypoxic Ischemic Encephalopathy Occurring after A Violent Suicide Attempt: A Case of Hanging. Dusunen Adam J. Psychiatry Neurol. Sci. 2018, 31, 228–230. DOI: 10.5350/DAJPN2018310214.
   Web of Science ®Google Scholar
• Orum, M. H.; Kara, M. Z.; Egilmez, O. B. Mean Platelet Volume and Neutrophil to Lymphocyte Ratio as Parameters to Indicate the Severity of Suicide Attempt. J. Immunoassay. Immunol. Chem. 2018, 39(6), 647–659. DOI: 10.1080/15321819.2018.1529682.
   PubMedGoogle Scholar
• Kara, M. Z.; Orum, M. H.; Egilmez, O. B. Relationship between Immune Cells and Violent/Nonviolent Suicide Attempts and Controls: What about the Lymphocyte-Related Ratios and Neutrophil-Related Parameters? Kaohsiung. J. Med. Sci. 2019, 35, 315–316. DOI: 10.1002/kjm2.12049.
   PubMed Web of Science ®Google Scholar
• Lu, Y. R.; Fu, X. Y.; Shi, L. G.; Jiang, Y.; Wu, J. L.; Weng, X. J.; Wang, Z. P.; Wu, X. Y.; Lin, Z.; Liu, W. B.; et al. Decreased Plasma Neuroactive Amino Acids and Increased Nitric Oxide Levels in Melancholic Major Depressive Disorder. BMJ. Psychiatry. 2014, 14, 123. DOI: 10.1186/1471-244X-14-123.
   PubMedGoogle Scholar
• Suzuki, E.; Yagi, G.; Nakaki, T.; Kanba, S.; Asai, M. Elevated Plasma Nitrate Levels in Depressive States. J. Affect. Disorders. 2001, 63, 221–224. DOI: 10.1016/S0165-0327(00)00164-6.
   PubMed Web of Science ®Google Scholar
• Yoshino, Y.; Ochi, S.; Yamazaki, K.; Nakata, S.; Abe, M.; Mori, Y.; Ueno, S. Antidepressant Action via the Nitric Oxide System: A Pilot Study in an Acute Depressive Model Induced by Arginin. Neurosci. Lett. 2015, 599, 69–74. DOI: 10.1016/j.neulet.2015.05.043.
   PubMed Web of Science ®Google Scholar
• Ozen, M. E.; Orum, M. H.; Kalenderoglu, A. Difficult Patient in Psychiatry Practice: A Case-Control Study. Adiyaman. Üni. Saglik. Bilimleri. Derg. 2018, 4(3), 1064–1073. DOI: 10.30569/adiyamansaglik.458680.
   Google Scholar
• Tanriverdi, N.; Taskin, T.; Duru, C.; Ozdal, P.; Ortac, S.; Ferat, E. Health–Related Quality of Life in Behçet Patients with Ocular Involvement. Jpn. J. Ophthalmol. 2003, 47(1), 85–92.
   PubMed Web of Science ®Google Scholar
• Karlidag, R.; Unal, S.; Evereklioglu, C.; Sipahi, B.; Er, H.; Yologlu, S. Stressful Life Events, Anxiety, Depression and Coping Mechanisms in Patients with Behcets’ Disease. J. Eur. Acad. Dermatol. Venereol. 2003, 17(6), 670–675. DOI: 10.1046/j.1468-3083.2003.00760.x.
   PubMed Web of Science ®Google Scholar
• Dursun, R.; Uguz, F.; Kaya, N.; Cilli, A. S.; Endogru, H. Psychiatric Disorders in Patients with Behçet’s Disease. Int. J. Psychiatry. Clin. Pract. 2007, 11(1), 16–20. DOI: 10.1080/13651500600811438.
   PubMed Web of Science ®Google Scholar
• Calikoglu, E.; Onder, M.; Cosar, B.; Candansavar, S. Depression, Anxiety Levels and General Psychological Profile in Behcet’s Disease. Dermatology. 2001, 203, 238–240. DOI: 10.1159/000051756.
   PubMed Web of Science ®Google Scholar
• Haznedaroglu, I. C.; Ozcebe, O. I.; Ozdemir, O.; Celik, I.; Dundar, S. V.; Kirazlı, Ş. Impaired Haemostatic Kinetics and Endothelial Function in Behcet’s Disease. J. Intern. Med. 1996, 240, 181–187. DOI: 10.1046/j.1365-2796.1996.396853000.x.
   PubMed Web of Science ®Google Scholar
• Akdemir, A.; Orsel, S.; Dağ, I.; Turkcapar, H.; Işcan, N.; Ozbay, H. Hamilton Depresyon Derecelendirme Ölceği (hddo)’nin Gecerliliği, Güvenilirliği Ve Klinikte Kullanımı. Psikiyatri Psikoloji Psikofarmakoloji Dergisi. 1996, 4(4), 251–259.
   Google Scholar
• Gurler, A.; Boyvat, A.; Tursen, U. Clinical Manifestations of Behçet’s Disease: An Analysis of 2147 Patients. Yonsei. Med. J. 1997, 38(6), 423–425. DOI: 10.3349/ymj.1997.38.6.423.
   PubMedGoogle Scholar
• Michaud, C. M.; Murray, M. C.; Bloom, B. R. Burden of Disease: Implications for Future Research. JAMA. 2001, 285, 535–539. DOI: 10.1001/jama.285.5.535.
   PubMed Web of Science ®Google Scholar
• Kawakita, H. Neurologic Aspects of Behçet’s Disease. J. Neurol. Sci. 1996, 5(3), 417–439. DOI: 10.1016/0022-510X(67)90083-4.
   Google Scholar
• Epstein, R. S. Psychiatric Aspects of Behçet’s Syndrome. J. Psychosom. Res. 1970, 14(2), 161–172. DOI: 10.1016/0022-3999(70)90026-7.
   PubMed Web of Science ®Google Scholar
• Orsucci, F. Behçet’s Disease and Psychosomatic Patterns of Thinking: A Single Case Study. Psychother. Psychosomatic. 1996, 65(2), 112–114. DOI: 10.1159/000289059.
   PubMed Web of Science ®Google Scholar
• Koptagel-Ilal, G.; Tuncer, O.; Enbiyaoglu, G.; Bayramoglu, Z. A Psychosomatic Investigation of Behcet’s Disease. Psychother. Psychosomatic. 1983, 40, 263–271. DOI: 10.1159/000287774.
   PubMed Web of Science ®Google Scholar
• Evereklioglu, C.; Turkoz, Y.; Er, H.; Inaloz, H. S.; Ozbek, E.; Cekmen, M. Increased Nitric Oxide Production in Patients with Behçet’s Disease: Is It a New Activity Marker? J. Am. Acad. Dermatol. 2002, 46(1), 50–54. DOI: 10.1067/mjd.2002.118338.
   PubMed Web of Science ®Google Scholar
• Waheed, A.; Hameed, K.; Khan, A. M.; Syed, J. A.; Mirza, A. I. The Burden of Anxiety and Depression among Patients with Chronic Rheumatologic Disorders at a Tertiary Care Hospital Clinic in Karachi, Pakistan. J. Pak. Med. Assoc. 2006, 56, 243–247.
   PubMedGoogle Scholar
• Nicholson, A.; Kuper, H.; Hemingway, H. Depression as an Aetiologic and Prognostic Factor in Coronary Heart Disease: A Meta-Analysis of 6362 Events among 146 538 Participants in 54 Observational Studies. Eur. Heart. J. 2006, 27, 2763–2774. DOI: 10.1093/eurheartj/ehl338.
   PubMed Web of Science ®Google Scholar
• Larson, S. L.; Owens, P. L.; Ford, D.; Eaton, W. Depressive Disorder, Dysthymic Disorder and Risk of Stroke. 13 Year Follow up Study from Baltimore ECA Study. Stroke. 2001, 32, 1979–1983. DOI: 10.1161/hs0901.094623.
   PubMed Web of Science ®Google Scholar
• Smit, F.; Beekman, A.; Cuijpers, P.; de Graaf, R.; Vollebergh, W. Selecting Key Variables for Depression Prevention: Results from a Population-Based Prospective Epidemiological Study. J. Affect. Disord. 2004, 81, 241–249. DOI: 10.1016/j.jad.2003.08.007.
   PubMed Web of Science ®Google Scholar
• Melikoglu, M.; Topkarci, Z. Is There a Relation between Clinical Disease Activity and Acute Phase Response in Behcet’s Disease? Int. J. Dermatol. 2014, 53, 250–254. DOI: 10.1111/ijd.12224.
   PubMed Web of Science ®Google Scholar
• Muftuoglu, A. U.; Yazici, H.; Yurdakul, S.; Tuzun, Y.; Pazarlı, H.; Gungen, G.; Deniz, S. Behçet’s Disease. Relation of Serum C-Reactive Protein and Erythrocyte Sedimentation Rates to Disease Activity. Int. J. Dermatol. 1986, 25, 235–239.
   PubMed Web of Science ®Google Scholar
• Cho, S. B.; Lee, J. H.; Ahn, K. J.; Bae, B. G.; Kim, T.; Park, Y. Anti-Cyclic Citrullinated Peptide Antibodies and Joint Involvement in Behçet’s Disease. Yonsei. Med. J. 2012, 53, 759–764. DOI: 10.3349/ymj.2012.53.4.759.
   PubMed Web of Science ®Google Scholar
• Koca, S. S.; Akbulut, H.; Dag, S.; Artas, H.; Isık, A. Anti-Cyclic Citrullinated Peptide Antibodies in Rheumatoid Arthritis and Behçet’s Disease. Tohoku. J. Exp. Med. 2007, 213, 297–304. DOI: 10.1620/tjem.213.297.
   PubMed Web of Science ®Google Scholar
• Kim, Y. K.; Paik, J. W.; Lee, S. W.; Yoon, D.; Han, C.; Lee, B. H. Increased Plasma Nitric Oxide Level Associated with Suicide Attempt in Depressive Patients. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2006, 30, 1091–1096. DOI: 10.1016/j.pnpbp.2006.04.008.
   PubMed Web of Science ®Google Scholar
• Chrapko, W. E.; Jurasz, P.; Radomski, M. W.; Lara, N.; Archer, S. L.; Le Mellédo, J. M. Decreased Platelet Nitric Oxide Synthase Activity and Plasma Nitric Oxide Metabolites in Major Depressive Disorder. Biol. Psychiatry. 2004, 56, 129–134. DOI: 10.1016/j.biopsych.2004.03.003.
   PubMed Web of Science ®Google Scholar
• Herken, H.; Gurel, A.; Selek, S.; Armutcu, F.; Ozen, M. E.; Bulut, M.; Kap, O.; Yumru, M.; Savas, H. A.; Akyol, O. Adenosine Deaminase, Nitric Oxide, Superoxide Dismutase, and Xanthine Oxidase in Patients with Major Depression: Impact of Antidepressant Treatment. Arch. Med. Res. 2007, 38, 247–252. DOI: 10.1016/j.arcmed.2006.10.005.
   PubMed Web of Science ®Google Scholar
• Isik, A.; Koca, S. S.; Ustundag, B.; Selek, S. Decreased Total Antioxidant Response and Increased Oxidative Stress in Behcet’s Disease. Tohoku. J. Exp. Med. 2007, 212(2), 133–141. DOI: 10.1620/tjem.212.133.
   PubMed Web of Science ®Google Scholar